M C Caldwell - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

M C Caldwell

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Clinical Therapeutics|August 30, 2000

Safety and immunogenicity profile of a recombinant outer-surface protein A Lyme disease vaccine: clinical trial of a 3-dose schedule at 0, 1, and 2 monthsR T Schoen, V K Sikand, M C Caldwell, et al.

The Journal of Urology|November 7, 2001

Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasiaT A Stamey, J A Warrington, M C Caldwell, et al.

Free Radical Biology & Medicine|December 21, 2000

Enhanced sensitivity and long-term G2 arrest in hydrogen peroxide-treated Ku80-null cells are unrelated to DNA repair defectsE D Arrington, M C Caldwell, T S Kumaravel, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Clinical Therapeutics|August 30, 2000

Safety and immunogenicity profile of a recombinant outer-surface protein A Lyme disease vaccine: clinical trial of a 3-dose schedule at 0, 1, and 2 monthsR T Schoen, V K Sikand, M C Caldwell, et al.

The Journal of Urology|November 7, 2001

Molecular genetic profiling of Gleason grade 4/5 prostate cancers compared to benign prostatic hyperplasiaT A Stamey, J A Warrington, M C Caldwell, et al.

Free Radical Biology & Medicine|December 21, 2000

Enhanced sensitivity and long-term G2 arrest in hydrogen peroxide-treated Ku80-null cells are unrelated to DNA repair defectsE D Arrington, M C Caldwell, T S Kumaravel, et al.

Pageof 2